title: Membranous nephropathy: recurrence after kidney transplantation.
abstract: BACKGROUND
  It is supposed that about 5% of dialysis patients had membranous nephropathy as a cause for their renal failure. Despite of this prevalence, only 33 cases of recurrent membranous nephropathy after kidney transplantation have been reported in the English literature.
  
  
  METHODS
  Among 509 recipients of renal allografts, membranous glomerulonephritis was the cause of renal failure in five patients, who received six transplants.
  
  
  RESULTS
  Recurrence of the disease was observed in three allografts (50%) in three patients, all of them were on treatment with cyclosporin and low-dose prednisone. Proteinuria appeared at 2, 5 and 19 months after grafting. One patient experienced a spontaneous remission after 12 months and he is free from proteinuria and with good renal function after 5 years. The remaining two patients presented progressive renal function deterioration and returned to haemodialysis 24 and 17 months after th appearance of proteinuria. In these patients increasing the immunosuppression did not produce any beneficial effect. One of those patients underwent a second transplant; recurrence of the membranous nephropathy has not been observed after 3 years of follow-up.
  
  
  CONCLUSIONS
  In this study three new cases of recurrence of membranous nephropathy are reported. One patient experienced a spontaneous remission of proteinuria. Recurrence of membranous nephropathy in renal allograft was very high in our series. Its appearance was associated with poor prognosis of the graft in most patients, although spontaneous remission of proteinuria is possible.
authors.affiliation: Department of Nephrology, Hospital Ramón y Cajal, Madrid, Spain.
authors.forename: R
authors.initials: R
authors.lastname: Marcen
authors.forename: F
authors.initials: F
authors.lastname: Mampaso
authors.forename: J L
authors.initials: JL
authors.lastname: Teruel
authors.forename: M E
authors.initials: ME
authors.lastname: Rivera
authors.forename: L
authors.initials: L
authors.lastname: Orofino
authors.forename: J
authors.initials: J
authors.lastname: Navarro-Antolin
authors.forename: J
authors.initials: J
authors.lastname: Ortuño
mesh_terms: D000328:Adult; D016572:Cyclosporine / Q000627:therapeutic use; D005455:Fluorescent Antibody Technique; D015433:Glomerulonephritis, Membranous / Q000473:pathology / Q000601:surgery* / Q000628:therapy; D006801:Humans; D007668:Kidney / Q000473:pathology / Q000503:physiopathology; D016030:Kidney Transplantation; D008297:Male; D008854:Microscopy, Electron; D008875:Middle Aged; D011182:Postoperative Care; D011183:Postoperative Complications; D011241:Prednisone / Q000627:therapeutic use; D011507:Proteinuria / Q000209:etiology; D012008:Recurrence; D006435:Renal Dialysis
chemical_list: D016572:Cyclosporine; D011241:Prednisone